]Prevalence of carotid atherosclerosis in hypertension: Preliminary baseline data from the European Lacidipine Study on Atherosclerosis (ELSA)

A. Zanchetti

Research output: Contribution to journalArticle

Abstract

In the ELSA trial, the effects of lacidipine-based treatment and β-blocker (atenolol)-based treatment on the development and progression of carotid wall alterations are assessed in hypertensive patients. The primary endpoint of this study is the rate of change in the intima-media thickness of the carotid artery wall, measured with B-mode ultrasound. About 2300 hypertensive patients have been recruited and randomized to either of the antihypertensive agents. Baseline data for 1965 patients are available, showing a high prevalence of carotid wall lesions: about 82% of the subjects have an intima-media thickness ≤1.3 mm, defined as plaque in the ELSA protocol; 16% of the subjects have intima-media thickening (≤1.0 mm,

Original languageEnglish
Pages (from-to)30-35
Number of pages6
JournalBlood Pressure, Supplement
Volume5
Issue number4
Publication statusPublished - 1996

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Fingerprint Dive into the research topics of ']Prevalence of carotid atherosclerosis in hypertension: Preliminary baseline data from the European Lacidipine Study on Atherosclerosis (ELSA)'. Together they form a unique fingerprint.

  • Cite this